These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9500474)

  • 61. Suppression of tumorigenicity by the cell-cycle-dependent control of cellular differentiation and proliferation.
    Wille JJ; Scott RE
    Int J Cancer; 1986 Jun; 37(6):875-81. PubMed ID: 3710616
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The complexities of PKCα signaling in cancer.
    Black AR; Black JD
    Adv Biol Regul; 2021 May; 80():100769. PubMed ID: 33307285
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Modulating PKCα Activity to Target Wnt/β-Catenin Signaling in Colon Cancer.
    Dupasquier S; Blache P; Picque Lasorsa L; Zhao H; Abraham JD; Haigh JJ; Ychou M; Prévostel C
    Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31109112
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Stabilization of Sur8 via PKCα/δ degradation promotes transformation and migration of colorectal cancer cells.
    Lee KH; Jeong WJ; Cha PH; Lee SK; Min DS; Choi KY
    Oncotarget; 2017 Dec; 8(70):115596-115608. PubMed ID: 29383184
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Protein kinase C (PKC) as a drug target in chronic lymphocytic leukemia.
    Kazi JU; Kabir NN; Rönnstrand L
    Med Oncol; 2013 Dec; 30(4):757. PubMed ID: 24174318
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A short primer on the calcium sensing receptor: an important cog in the colon cancer wheel?
    Ghevariya V; Anand S
    Dig Dis Sci; 2011 Feb; 56(2):279-84. PubMed ID: 20556514
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Expression of protein kinase C family in human hepatocellular carcinoma.
    Lu HC; Chou FP; Yeh KT; Chang YS; Hsu NC; Chang JG
    Pathol Oncol Res; 2010 Sep; 16(3):385-91. PubMed ID: 19949911
    [TBL] [Abstract][Full Text] [Related]  

  • 68. PKCalpha tumor suppression in the intestine is associated with transcriptional and translational inhibition of cyclin D1.
    Pysz MA; Leontieva OV; Bateman NW; Uronis JM; Curry KJ; Threadgill DW; Janssen KP; Robine S; Velcich A; Augenlicht LH; Black AR; Black JD
    Exp Cell Res; 2009 May; 315(8):1415-28. PubMed ID: 19232344
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Protein kinase C isozymes as therapeutic targets for treatment of human cancers.
    Fields AP; Murray NR
    Adv Enzyme Regul; 2008; 48():166-78. PubMed ID: 18167314
    [No Abstract]   [Full Text] [Related]  

  • 70. Suppression of azoxymethane-induced colon cancer development in rats by a prostaglandin E receptor EP1-selective antagonist.
    Niho N; Mutoh M; Kitamura T; Takahashi M; Sato H; Yamamoto H; Maruyama T; Ohuchida S; Sugimura T; Wakabayashi K
    Cancer Sci; 2005 May; 96(5):260-4. PubMed ID: 15904466
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Extracellular pressure stimulates colon cancer cell proliferation via a mechanism requiring PKC and tyrosine kinase signals.
    Walsh MF; Woo RK; Gomez R; Basson MD
    Cell Prolif; 2004 Dec; 37(6):427-41. PubMed ID: 15548175
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inhibition of growth-factor-induced phosphorylation and activation of protein kinase B/Akt by atypical protein kinase C in breast cancer cells.
    Mao M; Fang X; Lu Y; Lapushin R; Bast RC; Mills GB
    Biochem J; 2000 Dec; 352 Pt 2(Pt 2):475-82. PubMed ID: 11085941
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Protein kinase C signaling mediates a program of cell cycle withdrawal in the intestinal epithelium.
    Frey MR; Clark JA; Leontieva O; Uronis JM; Black AR; Black JD
    J Cell Biol; 2000 Nov; 151(4):763-78. PubMed ID: 11076962
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Transforming growth factor beta1 ameliorates intestinal epithelial barrier disruption by Cryptosporidium parvum in vitro in the absence of mucosal T lymphocytes.
    Roche JK; Martins CA; Cosme R; Fayer R; Guerrant RL
    Infect Immun; 2000 Oct; 68(10):5635-44. PubMed ID: 10992464
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Protein Kinase-zeta inhibits collagen I-dependent and anchorage-independent growth and enhances apoptosis of human Caco-2 cells.
    Mustafi R; Cerda S; Chumsangsri A; Fichera A; Bissonnette M
    Mol Cancer Res; 2006 Sep; 4(9):683-94. PubMed ID: 16940160
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Increased protein kinase C alpha expression in human colonic Caco-2 cells after insertion of human Ha-ras or polyoma virus middle T oncogenes.
    Delage S; Chastre E; Empereur S; Wicek D; Veissiére D; Capeau J; Gespach C; Cherqui G
    Cancer Res; 1993 Jun; 53(12):2762-70. PubMed ID: 8504416
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inhibition of expression of PKC-alpha by antisense mRNA is associated with diminished cell growth and inhibition of amylase secretion by AR4-2J cells.
    Zhang X; Wen J; Aletta JM; Rubin RP
    Exp Cell Res; 1997 May; 233(1):225-31. PubMed ID: 9184091
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Protein kinase C iota: human oncogene, prognostic marker and therapeutic target.
    Fields AP; Regala RP
    Pharmacol Res; 2007 Jun; 55(6):487-97. PubMed ID: 17570678
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Decreased PKC-alpha expression increases cellular proliferation, decreases differentiation, and enhances the transformed phenotype of CaCo-2 cells.
    Scaglione-Sewell B; Abraham C; Bissonnette M; Skarosi SF; Hart J; Davidson NO; Wali RK; Davis BH; Sitrin M; Brasitus TA
    Cancer Res; 1998 Mar; 58(5):1074-81. PubMed ID: 9500474
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.